T. Rowe Price Investment Management, Inc. Avanos Medical, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Avanos Medical, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,757,576 shares of AVNS stock, worth $40.5 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,757,576
Previous 3,011,312
24.78%
Holding current value
$40.5 Million
Previous $47.9 Million
12.32%
% of portfolio
0.04%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding AVNS
# of Institutions
309Shares Held
42.7MCall Options Held
3.5KPut Options Held
13.2K-
Black Rock Inc. New York, NY7.01MShares$75.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$48.2 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.58MShares$27.8 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2MShares$21.6 Million0.44% of portfolio
-
Brown Advisory Inc1.93MShares$20.8 Million0.04% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $502M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...